Authors: Wiedemann Á; Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary., Szita VR; Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary., Horváth R; Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary., Szederjesi A; Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary., Sebő A; Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary., Tóth AD; Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary., Masszi T; Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary., Varga G; Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary.

Source: Pathology oncology research : POR [Pathol Oncol Res] 2023 Apr 28; Vol. 29, pp. 1611171. Date of Electronic Publication: 2023 Apr 28 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Media S. A Country of Publication: Switzerland NLM ID: 9706087 Publication Model: eCollection Cited Medium: Internet ISSN: 1532-2807 (Electronic) Linking ISSN: 12194956 NLM ISO Abbreviation: Pathol Oncol Res Subsets: MEDLINE

MeSH Terms: B-Cell Maturation Antigen* , Multiple Myeloma*/diagnosis , Multiple Myeloma*/therapy, Humans ; Biomarkers ; Prognosis

Authors: Yoneyama T; Quantitative Solutions, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, United States of America., Kim MS; Global Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, United States of America., Piatkov K; Global Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, United States of America., Wang H; Global Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, United States of America., Zhu AZX; Quantitative Solutions, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, United States of America.

Source: PLoS computational biology [PLoS Comput Biol] 2022 Jul 15; Vol. 18 (7), pp. e1009715. Date of Electronic Publication: 2022 Jul 15 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238922 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7358 (Electronic) Linking ISSN: 1553734X NLM ISO Abbreviation: PLoS Comput Biol Subsets: MEDLINE

Authors: Lin Z; Department of Pediatric Nephrology and Rheumatology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, China., Yu N; Department of Pediatric Nephrology and Rheumatology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, China., Cheng C; Department of Pediatric Nephrology and Rheumatology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, China., Jin B; Department of Pediatric Nephrology and Rheumatology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, China., Zhang Q; Department of Pediatric Nephrology and Rheumatology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, China., Zhuang H; Department of Pediatric Nephrology and Rheumatology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, China., Jiang X; Department of Pediatric Nephrology and Rheumatology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, China.

Source: Lupus [Lupus] 2023 Apr; Vol. 32 (5), pp. 680-687. Date of Electronic Publication: 2023 Mar 13.

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9204265 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0962 (Electronic) Linking ISSN: 09612033 NLM ISO Abbreviation: Lupus Subsets: MEDLINE

Authors: Bujarski S; James R. Berenson, MD, Inc., West Hollywood, California, USA., Sutanto C; OncoTracker, West Hollywood, California, USA., Spektor TM; Oncotherapeutics, West Hollywood, California, USA., To J; Oncotherapeutics, West Hollywood, California, USA., Swift RA; James R. Berenson, MD, Inc., West Hollywood, California, USA., Green T; James R. Berenson, MD, Inc., West Hollywood, California, USA., Eades BR; James R. Berenson, MD, Inc., West Hollywood, California, USA., Emamy-Sadr M; James R. Berenson, MD, Inc., West Hollywood, California, USA., Souther E; OncoTracker, West Hollywood, California, USA., Berenson JR; James R. Berenson, MD, Inc., West Hollywood, California, USA.; OncoTracker, West Hollywood, California, USA.; Oncotherapeutics, West Hollywood, California, USA.; Institute for Myeloma and Bone Cancer Research, West Hollywood, California, USA.

Source: Hematological oncology [Hematol Oncol] 2022 Apr; Vol. 40 (2), pp. 243-248. Date of Electronic Publication: 2022 Jan 15.

Publication Type: Clinical Trial, Phase I; Journal Article

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE

Authors: Maples KT; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia., Scott SA; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia., Lonial S; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia.

Source: Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2023 May; Vol. 21 (5), pp. 247-256.

Publication Type: Journal Article; Review

Journal Info: Publisher: Millennium Medical Pub Country of Publication: United States NLM ID: 101167661 Publication Model: Print Cited Medium: Internet ISSN: 1543-0790 (Print) Linking ISSN: 15430790 NLM ISO Abbreviation: Clin Adv Hematol Oncol Subsets: MEDLINE

Authors: Rodriguez-Otero P; Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Centro de Investigación Biomédica en Red Cáncer, Pamplona, Spain., San-Miguel JF; Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Centro de Investigación Biomédica en Red Cáncer, Pamplona, Spain.

Source: Hematology. American Society of Hematology. Education Program [Hematology Am Soc Hematol Educ Program] 2022 Dec 09; Vol. 2022 (1), pp. 180-189.

Publication Type: Review; Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 100890099 Publication Model: Print Cited Medium: Internet ISSN: 1520-4383 (Electronic) Linking ISSN: 15204383 NLM ISO Abbreviation: Hematology Am Soc Hematol Educ Program Subsets: MEDLINE

MeSH Terms: B-Cell Maturation Antigen* , Multiple Myeloma*/therapy, Humans ; Neoplasm Recurrence, Local ; Immunotherapy, Adoptive ; Antigens, CD19

Authors: Stohl W; Division of Rheumatology, Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA., Yu N; Division of Rheumatology, Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA., Wu Y; Division of Rheumatology, Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA.

Source: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2022 Dec 01; Vol. 209 (11), pp. 2133-2140. Date of Electronic Publication: 2022 Oct 26.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Association of Immunologists Country of Publication: United States NLM ID: 2985117R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1550-6606 (Electronic) Linking ISSN: 00221767 NLM ISO Abbreviation: J Immunol Subsets: MEDLINE

MeSH Terms: B-Cell Maturation Antigen* , B-Lymphocyte Subsets* , T-Lymphocytes*, Animals ; Mice ; B-Lymphocytes ; Forkhead Transcription Factors/genetics ; Forkhead Transcription Factors/metabolism ; Mice, Inbred C57BL ; B-Cell Activation Factor Receptor/metabolism

Authors: Xu Y; Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-Fang Avenue, Wuhan, Hubei, 430030, P. R. China., Mao X; Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-Fang Avenue, Wuhan, Hubei, 430030, P. R. China.; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, 430030, Hubei, China., Que Y; Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-Fang Avenue, Wuhan, Hubei, 430030, P. R. China., Xu M; Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-Fang Avenue, Wuhan, Hubei, 430030, P. R. China., Li C; Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-Fang Avenue, Wuhan, Hubei, 430030, P. R. China., Almeida VDF; Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China., Wang D; Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-Fang Avenue, Wuhan, Hubei, 430030, P. R. China. diwong@tjh.tjmu.edu.cn.; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, 430030, Hubei, China. diwong@tjh.tjmu.edu.cn., Li C; Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-Fang Avenue, Wuhan, Hubei, 430030, P. R. China. cunrui5650@hust.edu.cn.; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, 430030, Hubei, China. cunrui5650@hust.edu.cn.

Source: BMC cancer [BMC Cancer] 2023 Feb 07; Vol. 23 (1), pp. 123. Date of Electronic Publication: 2023 Feb 07.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Authors: Ri M; Department of Hematology and Oncology, Nagoya City University Hospital, Nagoya, Japan., Suzuki K; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan., Ishida T; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan., Kuroda J; Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan., Tsukamoto T; Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan., Teshima T; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan., Goto H; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan., Jackson CC; Janssen Research & Development, LLC; Bridgewater, New Jersey, USA., Sun H; Janssen Research & Development, LLC; Bridgewater, New Jersey, USA., Pacaud L; Legend Biotech, Piscataway, New Jersey, USA., Fujikawa E; Janssen Pharmaceutical KK, Tokyo, Japan., Yeh TM; Janssen Research & Development, LLC; Bridgewater, New Jersey, USA., Hatayama T; Janssen Pharmaceutical KK, Tokyo, Japan., Aida K; Janssen Pharmaceutical KK, Tokyo, Japan., Sunagawa Y; Janssen Pharmaceutical KK, Tokyo, Japan., Iida S; Department of Hematology and Oncology, Nagoya City University Hospital, Nagoya, Japan.

Source: Cancer science [Cancer Sci] 2022 Dec; Vol. 113 (12), pp. 4267-4276. Date of Electronic Publication: 2022 Oct 07.

Publication Type: Clinical Trial, Phase II; Journal Article

Journal Info: Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE

Authors: Wong DP; Department of Pathology, Case Western Reserve University, Cleveland, OH, USA., Roy NK; Division of Hematology/Oncology, Department of Medicine, Case Western Reserve University, Cleveland, OH, USA., Zhang K; Division of Hematology/Oncology, Department of Medicine, Case Western Reserve University, Cleveland, OH, USA., Anukanth A; Division of Pediatric Hematology/Oncology, Angie Fowler AYA Cancer Institute, UH Rainbow Babies & Children's Hospital, Cleveland, OH, USA., Asthana A; Division of Hematology/Oncology, Department of Medicine, Case Western Reserve University, Cleveland, OH, USA., Shirkey-Son NJ; Luminary Therapeutics, Minneapolis, MN, USA., Dunmire S; Luminary Therapeutics, Minneapolis, MN, USA., Jones BJ; Bio-Techne, Minneapolis, MN, USA., Lahr WS; Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Center for Genome Engineering, University of Minnesota, Minneapolis, MN, USA.; Stem Cell Institute, University of Minnesota, Minneapolis, MN, USA., Webber BR; Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Center for Genome Engineering, University of Minnesota, Minneapolis, MN, USA.; Stem Cell Institute, University of Minnesota, Minneapolis, MN, USA., Moriarity BS; Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Center for Genome Engineering, University of Minnesota, Minneapolis, MN, USA.; Stem Cell Institute, University of Minnesota, Minneapolis, MN, USA., Caimi P; Division of Hematology/Oncology, Department of Medicine, Case Western Reserve University, Cleveland, OH, USA.; The Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA., Parameswaran R; Division of Hematology/Oncology, Department of Medicine, Case Western Reserve University, Cleveland, OH, USA. rxp278@case.edu.; The Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA. rxp278@case.edu.

Source: Nature communications [Nat Commun] 2022 Jan 11; Vol. 13 (1), pp. 217. Date of Electronic Publication: 2022 Jan 11.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Authors: Bujarski S; Institute for Myeloma and Bone Cancer Research, West Hollywood, CA, USA.; Berenson Cancer Center, West Hollywood, CA, USA., Goldwater MS; Berenson Cancer Center, West Hollywood, CA, USA., Regidor BS; Berenson Cancer Center, West Hollywood, CA, USA., Jew S; Institute for Myeloma and Bone Cancer Research, West Hollywood, CA, USA.; Berenson Cancer Center, West Hollywood, CA, USA., Daniely D; Berenson Cancer Center, West Hollywood, CA, USA., Swift RA; Berenson Cancer Center, West Hollywood, CA, USA., Eades BM; Berenson Cancer Center, West Hollywood, CA, USA., Emamy-Sadr M; Berenson Cancer Center, West Hollywood, CA, USA., Souther E; OncoTracker, West Hollywood, CA, USA., Li M; Institute for Myeloma and Bone Cancer Research, West Hollywood, CA, USA., Wang C; Institute for Myeloma and Bone Cancer Research, West Hollywood, CA, USA., Xu N; Institute for Myeloma and Bone Cancer Research, West Hollywood, CA, USA., Chen H; Institute for Myeloma and Bone Cancer Research, West Hollywood, CA, USA., Spektor TM; Oncotherapeutics, West Hollywood, CA, USA., Berenson JR; Institute for Myeloma and Bone Cancer Research, West Hollywood, CA, USA.; Berenson Cancer Center, West Hollywood, CA, USA.; OncoTracker, West Hollywood, CA, USA.; Oncotherapeutics, West Hollywood, CA, USA.

Source: European journal of haematology [Eur J Haematol] 2021 Sep; Vol. 107 (3), pp. 318-323. Date of Electronic Publication: 2021 Jun 14.

Publication Type: Journal Article

Journal Info: Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE

Authors: Hirano A; Inflammation and Immunology, Graduate School of Medical Science, 12898Kyoto Prefectural University of Medicine, Kyoto, Japan., Fujioka K; Inflammation and Immunology, Graduate School of Medical Science, 12898Kyoto Prefectural University of Medicine, Kyoto, Japan., Kida T; Inflammation and Immunology, Graduate School of Medical Science, 12898Kyoto Prefectural University of Medicine, Kyoto, Japan., Omura S; Inflammation and Immunology, Graduate School of Medical Science, 12898Kyoto Prefectural University of Medicine, Kyoto, Japan., Sofue H; Inflammation and Immunology, Graduate School of Medical Science, 12898Kyoto Prefectural University of Medicine, Kyoto, Japan., Sakashita A; Inflammation and Immunology, Graduate School of Medical Science, 12898Kyoto Prefectural University of Medicine, Kyoto, Japan., Sagawa T; Inflammation and Immunology, Graduate School of Medical Science, 12898Kyoto Prefectural University of Medicine, Kyoto, Japan., Isoda Y; Inflammation and Immunology, Graduate School of Medical Science, 12898Kyoto Prefectural University of Medicine, Kyoto, Japan., Kasahara A; Inflammation and Immunology, Graduate School of Medical Science, 12898Kyoto Prefectural University of Medicine, Kyoto, Japan., Sagawa R; Inflammation and Immunology, Graduate School of Medical Science, 12898Kyoto Prefectural University of Medicine, Kyoto, Japan., Fujii W; Inflammation and Immunology, Graduate School of Medical Science, 12898Kyoto Prefectural University of Medicine, Kyoto, Japan., Seno T; Inflammation and Immunology, Graduate School of Medical Science, 12898Kyoto Prefectural University of Medicine, Kyoto, Japan., Wada M; Inflammation and Immunology, Graduate School of Medical Science, 12898Kyoto Prefectural University of Medicine, Kyoto, Japan., Kohno M; Inflammation and Immunology, Graduate School of Medical Science, 12898Kyoto Prefectural University of Medicine, Kyoto, Japan., Kawahito Y; Inflammation and Immunology, Graduate School of Medical Science, 12898Kyoto Prefectural University of Medicine, Kyoto, Japan.

Source: Lupus [Lupus] 2023 Jan; Vol. 32 (1), pp. 63-73. Date of Electronic Publication: 2022 Oct 31.

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9204265 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0962 (Electronic) Linking ISSN: 09612033 NLM ISO Abbreviation: Lupus Subsets: MEDLINE

Authors: Kapinos KA; Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Harold C. Simmons Comprehensive Cancer Center, 12334University of Texas Southwestern Medical Center, Dallas, TX, USA.; RAND Corporation, Arlington, VA, USA., Hu E; Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA., Trivedi J; Department of Pharmacy, 12334University of Texas Southwestern Medical Center, Dallas 75390-9096, TX, USA., Geethakumari PR; Division of Hematologic Malignancies and Cellular Therapy, Department of Internal Medicine, 12334University of Texas Southwestern Medical Center, Dallas, TX, USA., Kansagra A; Harold C. Simmons Comprehensive Cancer Center, 12334University of Texas Southwestern Medical Center, Dallas, TX, USA.; Division of Hematologic Malignancies and Cellular Therapy, Department of Internal Medicine, 12334University of Texas Southwestern Medical Center, Dallas, TX, USA.

Source: Cancer control : journal of the Moffitt Cancer Center [Cancer Control] 2023 Jan-Dec; Vol. 30, pp. 10732748221142945.

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publishing Country of Publication: United States NLM ID: 9438457 Publication Model: Print Cited Medium: Internet ISSN: 1526-2359 (Electronic) Linking ISSN: 10732748 NLM ISO Abbreviation: Cancer Control Subsets: MEDLINE

Authors: Lonial S; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.; Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia.

Source: Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2023 Jan; Vol. 21 (1), pp. 43-45.

Publication Type: Interview

Journal Info: Publisher: Millennium Medical Pub Country of Publication: United States NLM ID: 101167661 Publication Model: Print Cited Medium: Internet ISSN: 1543-0790 (Print) Linking ISSN: 15430790 NLM ISO Abbreviation: Clin Adv Hematol Oncol Subsets: MEDLINE

Authors: Mei H; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. hmei@hust.edu.cn.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, 430022, China. hmei@hust.edu.cn., Li C; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, 430022, China., Jiang H; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, 430022, China., Zhao X; Institute of Hematology, Jingzhou Central Hospital, The Second Clinical Medical College, Yangtze University, Jingzhou, 434020, China., Huang Z; Institute of Hematology, Jingzhou Central Hospital, The Second Clinical Medical College, Yangtze University, Jingzhou, 434020, China., Jin D; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, 430022, China.; Zhejiang Cellyan Biotechnology Co. Ltd, Jiaxin, 314001, China., Guo T; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, 430022, China., Kou H; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, 430022, China., Liu L; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, 430022, China., Tang L; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, 430022, China., Yin P; Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China., Wang Z; Drug Clinical Trial Institution, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Ai L; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, 430022, China., Ke S; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, 430022, China., Xia Y; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, 430022, China., Deng J; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, 430022, China., Chen L; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China., Cai L; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China., Sun C; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China., Xia L; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, 430022, China., Hua G; Zhejiang Cellyan Biotechnology Co. Ltd, Jiaxin, 314001, China., Hu Y; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. dr_huyu@126.com.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, 430022, China. dr_huyu@126.com.

Source: Journal of hematology & oncology [J Hematol Oncol] 2021 Oct 09; Vol. 14 (1), pp. 161. Date of Electronic Publication: 2021 Oct 09.

Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE

Authors: Tan CR; Myeloma Service Department of Medicine, Memorial Sloan Kettering Cancer Center, 530 E 74th Street, New York, NY, 10021, USA. tanc4@mskcc.org., Shah UA; Myeloma Service Department of Medicine, Memorial Sloan Kettering Cancer Center, 530 E 74th Street, New York, NY, 10021, USA.

Source: Current hematologic malignancy reports [Curr Hematol Malig Rep] 2021 Oct; Vol. 16 (5), pp. 367-383. Date of Electronic Publication: 2021 Aug 25.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review

Journal Info: Publisher: Current Science Country of Publication: United States NLM ID: 101262565 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-822X (Electronic) Linking ISSN: 15588211 NLM ISO Abbreviation: Curr Hematol Malig Rep Subsets: MEDLINE

Authors: Jessurun JG; Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, P.O. Box 2040, 3000 CA, the Netherlands. Electronic address: j.g.jessurun@erasmusmc.nl., Hunfeld NGM; Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, P.O. Box 2040, 3000 CA, the Netherlands; Department of Intensive Care, Erasmus MC, University Medical Center Rotterdam, Rotterdam, P.O. Box 2040, 3000 CA, the Netherlands. Electronic address: n.hunfeld@erasmusmc.nl., van Dijk M; Department of Internal Medicine, Section of Nursing Science, Erasmus MC, University Medical Center Rotterdam, Rotterdam, P.O. Box 2040, 3000 CA, the Netherlands. Electronic address: m.vandijk3@erasmusmc.nl., van den Bemt PMLA; Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, P.O. Box 2040, 3000 CA, the Netherlands; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, P.O. Box 30.001, 9700 RB, the Netherlands. Electronic address: p.m.l.a.van.den.bemt@umcg.nl., Polinder S; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, P.O. Box 2040, 3000 CA, the Netherlands. Electronic address: s.polinder@erasmusmc.nl.

Source: Research in social & administrative pharmacy : RSAP [Res Social Adm Pharm] 2022 Nov; Vol. 18 (11), pp. 3980-3987. Date of Electronic Publication: 2022 Jul 13.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101231974 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1934-8150 (Electronic) Linking ISSN: 15517411 NLM ISO Abbreviation: Res Social Adm Pharm Subsets: MEDLINE

MeSH Terms: B-Cell Maturation Antigen* , Medication Systems, Hospital*, Cost-Benefit Analysis ; Hospitals ; Humans ; Pharmaceutical Preparations ; Prospective Studies

Authors: Sriram H; Hematopathology Laboratory, ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Kunjachan F; Hematopathology Laboratory, ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Khanka T; Hematopathology Laboratory, ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Gawai S; Hematopathology Laboratory, ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Ghogale S; Hematopathology Laboratory, ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Deshpande N; Hematopathology Laboratory, ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Girase K; Hematopathology Laboratory, ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Patil J; Hematopathology Laboratory, ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Chatterjee G; Hematopathology Laboratory, ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Rajpal S; Hematopathology Laboratory, ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Patkar NV; Hematopathology Laboratory, ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Bagal B; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Jain H; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Sengar M; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Hasan SK; Cell and Tumor Biology Group, ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Khattry N; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Subramanian PG; Hematopathology Laboratory, ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Gujral S; Hematopathology Laboratory, ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Tembhare PR; Hematopathology Laboratory, ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.

Source: Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2022 Nov; Vol. 102 (6), pp. 462-470. Date of Electronic Publication: 2022 Nov 08.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 101235690 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4957 (Electronic) Linking ISSN: 15524949 NLM ISO Abbreviation: Cytometry B Clin Cytom Subsets: MEDLINE

MeSH Terms: B-Cell Maturation Antigen*/metabolism , Multiple Myeloma*/metabolism, Adult ; Aged ; Humans ; Middle Aged ; Flow Cytometry ; Immunotherapy, Adoptive ; Neoplasm Recurrence, Local ; Male ; Female

Authors: Gaballa MR; Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, Massachusetts, USA., Maus MV; Department of Medicine, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, Massachusetts, USA mvmaus@mgh.harvard.edu.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Sep; Vol. 10 (9).

Publication Type: Editorial

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

MeSH Terms: B-Cell Maturation Antigen* , Receptors, Chimeric Antigen*/genetics, Humans ; Immunotherapy, Adoptive ; T-Lymphocytes

Authors: Manier S; Department of Hematology, Lille University Hospital, Lille, France; CANTHER, INSERM UMR-S1277 & CNRS UMR9020, Lille University, Lille, France. Electronic address: salomon.manier@chru-lille.fr., Ingegnere T; CANTHER, INSERM UMR-S1277 & CNRS UMR9020, Lille University, Lille, France., Escure G; Department of Hematology, Lille University Hospital, Lille, France; CANTHER, INSERM UMR-S1277 & CNRS UMR9020, Lille University, Lille, France., Prodhomme C; Department of Hematology, Lille University Hospital, Lille, France., Nudel M; Department of Hematology, Lille University Hospital, Lille, France., Mitra S; CANTHER, INSERM UMR-S1277 & CNRS UMR9020, Lille University, Lille, France., Facon T; Department of Hematology, Lille University Hospital, Lille, France. Electronic address: thierry.facon@chru-lille.fr.

Source: Blood reviews [Blood Rev] 2022 Jul; Vol. 54, pp. 100929. Date of Electronic Publication: 2022 Jan 21.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 8708558 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1681 (Electronic) Linking ISSN: 0268960X NLM ISO Abbreviation: Blood Rev Subsets: MEDLINE

MeSH Terms: B-Cell Maturation Antigen*/genetics , B-Cell Maturation Antigen*/therapeutic use , Multiple Myeloma*/pathology, Humans ; Immunotherapy, Adoptive ; Receptors, Chimeric Antigen ; T-Lymphocytes ; Tumor Microenvironment